Harvard Bioscience (HBIO) Non Operating Income (2010 - 2026)
Harvard Bioscience (HBIO) posted quarterly Non Operating Income of -$2.1 million for Q1 2026, down 89.43% year-over-year from -$20.2 million in Q1 2025, and up 65.86% quarter-over-quarter from -$6.2 million in Q4 2025.
Harvard Bioscience (HBIO) Non Operating Income (2010 - 2026) Analysis & Trends
Harvard Bioscience (HBIO) has reported Non Operating Income for 17 consecutive years, with -$2.1 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Non Operating Income fell 89.43% year-over-year to -$2.1 million; the TTM figure through Mar 2026 stood at -$11.1 million (down 184.85% YoY), while the FY2025 annual figure was -$8.8 million, down 61.46% from the prior year.
- Non Operating Income climbed to -$2.1 million in Q1 2026 per HBIO's latest filing, from -$6.2 million in the prior quarter.
- Across five years, Non Operating Income topped out at $579000.0 in Q4 2024 and bottomed at -$6.2 million in Q4 2025.
- Historically, Non Operating Income has averaged -$1.3 million across 5 years, with a median of -$928000.0 in 2022.
- Annual changes were most pronounced in 2024 — Non Operating Income soared 141.81% — and 2025, when it plunged 1178.93%.
- Harvard Bioscience's Non Operating Income stood at -$598000.0 in 2022, then slumped by 131.61% to -$1.4 million in 2023, then soared by 141.81% to $579000.0 in 2024, then slumped by 1178.93% to -$6.2 million in 2025, then surged by 65.86% to -$2.1 million in 2026.
- Business Quant data shows HBIO's Non Operating Income at -$2.1 million in Q1 2026, -$6.2 million in Q4 2025, and -$1.3 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non Op. Inc. (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 134.13 Bn | 128.91 Bn | 1.96 Bn | 82.70 Mn |
| 2 | Becton Dickinson | 52.76 Bn | 51.90 Bn | 2.32 Bn | - |
| 3 | Alcon | 35.81 Bn | 34.46 Bn | 1.68 Bn | - |
| 4 | Resmed | 33.72 Bn | 32.25 Bn | 861.22 Mn | 25.45 Mn |
| 5 | Medline | 29.38 Bn | 26.70 Bn | 2.22 Bn | -160.00 Mn |
| 6 | West Pharmaceutical Services | 25.00 Bn | 24.57 Bn | 329.20 Mn | -12.80 Mn |
| 7 | Solventum | 15.46 Bn | 15.06 Bn | 1.29 Bn | - |
| 8 | Cooper Companies | 14.88 Bn | 14.74 Bn | 735.40 Mn | 3.50 Mn |
| 9 | Baxter International | 13.58 Bn | 11.43 Bn | 1.03 Bn | - |
| 10 | Harvard Bioscience | 33.45 Mn | 26.94 Mn | 12.63 Mn | -1.92 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -1.92 Mn |
| Mar 31, 2026 | -2.13 Mn |
| Dec 31, 2025 | -6.25 Mn |
| Sep 30, 2025 | -1.33 Mn |
| Jun 30, 2025 | -1.44 Mn |
| Mar 31, 2025 | -1.13 Mn |
| Dec 31, 2024 | 579,000.00 |
| Sep 30, 2024 | -2.62 Mn |
| Jun 30, 2024 | -749,000.00 |
| Mar 31, 2024 | -751,000.00 |
| Dec 31, 2023 | -1.39 Mn |
| Sep 30, 2023 | 371,000.00 |
| Jun 30, 2023 | -2.89 Mn |
| Mar 31, 2023 | -542,000.00 |
| Dec 31, 2022 | -598,000.00 |
| Sep 30, 2022 | -928,000.00 |
| Jun 30, 2022 | -577,000.00 |
| Mar 31, 2022 | -306,000.00 |
| Dec 31, 2021 | -568,000.00 |
| Sep 30, 2021 | -373,000.00 |